February 14, 2022
EPS Holdings, Inc.
Allm Inc.
News Release

Web Seminar Held on Approaches to Achieve Patient-Centric Virtual/online
Clinical Trials
EPS Holdings, Inc. (Head Office: Shinjuku-ku, Tokyo; Representative Director: Hao Yan; hereinafter“EPS”) concluded a business partnership agreement with Allm Inc. (Head Office: Shibuya-ku,Tokyo; Representative Director and CEO: Teppei Sakano; hereinafter “Allm”) in March 2021 tocollaborate on and examine the launch of a joint EPSAM project for the purpose of building a digitalplatform that provides total coverage from development and sales support for pharmaceuticals,medical devices, and other medical products to health promotion and measures to prevent the spreadof disease. As part of this effort, EPS and Allm held a web seminar on January 27, 2022 to introduce
methods for the reasonable use of the Allm MySOS Personal Health Record (PHR) app which
inspired the EPSAM concept and the possibility of introducing this digital platform into patient andpublic involvement initiatives.

Upwards of 344 people participated in this seminar, which generate great interest in the concepts ofpatient and public involvement as well as virtual/online clinical trials.
This web seminar not only introduced the MySOS support app for life-saving and healthcare
developed and managed by Allm, but also proposed several ways to use MySOS which will improveuser friendliness, streamline clinical trials, and make it easier for patients to participate in clinical
trials from the CRA*1 and CRC*2 perspectives of EPS as a company actively involved in the sector.
This event also provided a chat section for seminar participants to share their ideas about which
proposal they felt would be the most useful.
As a result, a participant satisfaction survey showed that a total of 77.4% where either “Very Satisfied”
or “Satisfied” with the web seminar.

Q：How satisfied were you with the web seminar today?
Moderately
dissatisfied,
3.2%

Extremely
dissatisfied, 0.0%Neithersatisfied
nor…

Extremely
satisfied,
45.2%

Moderately
satisfied,32.3%

EPS is also advancing Virtual Go as framework to promote virtual/online clinical trials. In the future,
EPS and Allm will host a wide variety of web seminars as one effort to make virtual/online clinical
trials commonplace. We look forward to your participation.
■ EPS Virtual Go Framework
As a leading company supporting clinical study work, EPS is advancing the Virtual Go framework
to promote virtual/online clinical trials using its wealth of expertise and experience in data science,
which is backed by an extensive track record.

Virtual Go is a generic name for all EPS services used to promote virtual/online clinical trials.
Virtual Go always strives to satisfy two core ideas: “virtual/online clinical trials in which patients do
not have to visit medical institutions” and “virtual/online clinical trials in which CRAs do not haveto visit medical institutions.” To do this, EPS handles everything from the proposal to operation andmanagement of various schemes to advance virtual/online clinical trials right for the trial design andtype of disease. This includes DDC*3, online medical examinations, eConsent*4, eCOA*5, the use ofwearable devices, shipment of investigational product, home-visit nursing, and specimen collection.
Allm MySOS AppMySOS is an application that keeps a record of user and user’s family health and medical care, andsupports a smooth response to emergencies. It supports daily health management using personal
health records, first-aid and basic life support in case of emergencies, rescue requests, sharing ofinformation with medical professionals, and emergency contact of family. Users can even receive theresults of health checkups and PCR test, dialysis history, and other medical information fromaffiliated medical institutions.

About EPS Holdings, Inc.
EPS Holding, Inc. is a healthcare solutions provider that has been handling all processes from drug
discovery and development to marketing, sales, consulting, and various other solutions since its
founding as a pioneer CRO*6 in 1991. The Group broadened its businesses as well to bring new value
to pharmaceutical and medical device companies, hospitals, clinics, and academia through efforts that
include big data, AI, and regenerative medicine.
Name
Address
Representative
Established
CapitalHomepage

EPS Holdings, Inc.
Kagurazaka AK Building 6F, 1-8 Tsukudo-cho,Shinjuku-ku, Tokyo, Japan
Hao YANMay 30, 1991
100 million yen
https://www.eps holdings.co.jp/About Allm Inc.
Allm Inc. is a Japan-based company providing ICT mobile solutions to eliminate disparities andinefficiencies in healthcare, while increasing the access to quality care and wellbeing for all advocatedby its “All Medical” and “Shaping Healthcare” corporate message. Allm is actively engaged in global
expansion of its medical ICT business, which includes “Join,” a communication app for medical
professionals, and provides solutions to a total of 30 countries.
Name
Address
Representative
Established
CapitalHomepage

Allm Inc.
Shibuya Mark City West 16F, 1-12-1 Dogenzaka,
Shibuya-ku, Tokyo Japan
Teppei SAKANO
April 18, 2001100 million yen
https://www.allm.net/*1: CRA (Clinical Research Associate)*2: CRC (Clinical Research Coordinator)*3: DDC (Direct Data Capture)*4: eConsent (Electronic Consent)*5: eCOA (Electronic Clinical Outcome Assessment)*6: CRO (Contract Research Organization)

Contact:
EPS Holdings, Inc.
E-mail: epshlds-cco-pre@eps.co.jp

Allm Inc.
E-mail: press@allm.jp